Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) Cash from Investing Activities Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 8.16% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 26.15% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 51.85% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 75.05% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 33.33% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -129.09% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -2.94% |
| 10 | Amphastar Pharmaceuticals | 867.92 Mn | 696.78 Mn | 70.32 Mn | -38.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.25% |
| Dec 31, 2025 | -541.91% |
| Sep 30, 2025 | -8.74% |
| Jun 30, 2025 | 57.57% |
| Mar 31, 2025 | 46.60% |
| Dec 31, 2024 | -43.98% |
| Sep 30, 2024 | -109.36% |
| Jun 30, 2024 | -154.23% |
| Mar 31, 2024 | 55.39% |
| Dec 31, 2023 | -103.79% |
| Sep 30, 2023 | -78.79% |
| Jun 30, 2023 | -269.69% |
| Mar 31, 2023 | 10.12% |
| Dec 31, 2022 | 68.54% |
| Sep 30, 2022 | 6.43% |
| Jun 30, 2022 | 5.42% |
| Mar 31, 2022 | 15.10% |
| Dec 31, 2021 | -10.76% |
| Sep 30, 2021 | 33.60% |
| Jun 30, 2021 | 28.77% |